For: | Huang ML, Shen GT, Li NL. Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. World J Clin Cases 2022; 10(32): 11690-11701 [PMID: 36405275 DOI: 10.12998/wjcc.v10.i32.11690] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i32/11690.htm |
Number | Citing Articles |
1 |
Bo Zhou, Jie Li, Shuai Wu, Haomiao Zhang, Yuanbo Luo, Jingxiang Chen, Geng Chen. USP39/SMC4 promotes hepatoma cell proliferation and 5-FU resistance. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93029-x
|
2 |
Yujing Chen, Jingyi Zhang, Jinfeng Yang, Jiawei Zhao, Xiaotong Guo, Juzheng Zhang, Jinfeng Gan, Weijia Zhao, Siqi Chen, Xinwen Zhang, Yi Lin, Jiamin Jin. Exploring the cancerous nexus: the pivotal and diverse roles of USP39 in cancer development. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02480-9
|
3 |
Wenbiao Xiao, Bingwen Lin, Ying Wang, Peng Huang, Jiandong Lin, Xiongjian Xiao. USP31 PROMOTES THE INFLAMMATORY RESPONSE OF HUMAN LUNG ORGANOIDS TO LIPOPOLYSACCHARIDE TREATMENT. Shock 2025; 63(1): 110 doi: 10.1097/SHK.0000000000002464
|
4 |
Ziqi Chen, Meijun Zhong, Yuhui Lin, Wei Zhang, Yinghong Zhu, Lin Chen, Ziyao Huang, Kaiyuan Luo, Zhifeng Lu, Zhaoqi Huang, Yi Yan. METTL7B-induced histone lactylation prevents heart failure by ameliorating cardiac remodelling. Journal of Molecular and Cellular Cardiology 2025; 202: 64 doi: 10.1016/j.yjmcc.2025.03.006
|
5 |
Mohamad Bakkar, Sara Khalil, Komal Bhayekar, Narva Deshwar Kushwaha, Amirreza Samarbakhsh, Sadaf Dorandish, Holly Edwards, Q. Ping Dou, Yubin Ge, Navnath S. Gavande. Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects. Biomolecules 2025; 15(2): 240 doi: 10.3390/biom15020240
|
6 |
Xiaohan Wang, Sisi Wei, Wanzhao Li, Xiaojian Wei, Cong Zhang, Suli Dai, Ming Ma, Lianmei Zhao, Baoen Shan. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro. International Immunopharmacology 2023; 119: 110213 doi: 10.1016/j.intimp.2023.110213
|
7 |
Danielle Whitham, Pathea Bruno, Norman Haaker, Kathleen F. Arcaro, Brian T. Pentecost, Costel C. Darie. Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics. Expert Review of Proteomics 2024; 21(1-3): 81 doi: 10.1080/14789450.2024.2320158
|
8 |
Suaad Syed, Muhammad Yasir Khan Painda, Dawood Ghafoor, Dongjin Gu, Feng Wang. Physiological roles and therapeutic implications of USP6. Cell Death Discovery 2025; 11(1) doi: 10.1038/s41420-025-02466-0
|
9 |
Lili Kong, Xiaofeng Jin. Dysregulation of deubiquitination in breast cancer. Gene 2024; 902: 148175 doi: 10.1016/j.gene.2024.148175
|
10 |
Guangce Xia, Yulin Guo, Jiajia Zhang, Meng Han, Xiangchao Meng, Ji Lv. An Overview of the Deubiquitinase USP53: A Promising Diagnostic
Marker and Therapeutic Target. Current Protein & Peptide Science 2024; 25(9): 708 doi: 10.2174/0113892037292440240518194922
|
11 |
Pisong Li, Xiaoyu Zhu, Hui Qu, Zhongbin Han, Xingyu Yao, Yuan Wei, Baijun Li, Hongshen Chen. Synergistic Effect of Ubiquitin-Specific Protease 14 and Poly(ADP-Ribose) Glycohydrolase Co-Inhibition in BRCA1-Mutant, Poly(ADP-Ribose) Polymerase Inhibitor-Resistant Triple-Negative Breast Cancer Cells. OncoTargets and Therapy 2024; : 741 doi: 10.2147/OTT.S463217
|